During the past decade, Family Eye Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Family Eye Group" #1 collaborator was "National Eye Institute (NEI)" with 9 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Family Eye Group" are "Diabetic Macular Edema" (3 trials), "Nasolacrimal Duct Obstruction" (2 trials), "Proliferative Diabetic Retinopathy" (2 trials), "Amblyopia" (1 trials) and "Myopia" (1 trials). Many other conditions were trialed in "Family Eye Group" in a lesser frequency.

Most popular intervention types in "Family Eye Group" are "Drug" (5 trials), "Procedure" (4 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nasolacrimal intubation" (2 trials), "0.3 mg intravitreal ranibizumab" (1 trials), "0.5-mg Ranibizumab" (1 trials), "1.25 mg intravitreal bevacizumab" (1 trials) and "2.0 mg intravitreal aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Family Eye Group" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Family Eye Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Family Eye Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Family Eye Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".